Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,204,900 | 602,562 | 570,721 | 514,542 | 759,598 |
| Marketable Securities | 640,500 | 620,167 | 1,134,989 | 1,176,115 | 448,146 |
| Receivables | 1,292,400 | 824,406 | 686,848 | 584,603 | 605,329 |
| Inventories | 804,000 | 659,003 | 447,373 | 326,843 | 289,066 |
| Other current assets | 593,200 | 478,796 | 404,406 | 373,324 | 438,281 |
| TOTAL | $4,535,000 | $3,184,934 | $3,244,337 | $2,975,427 | $2,540,420 |
| Non-Current Assets | |||||
| PPE Net | 1,765,700 | 1,750,710 | 1,742,200 | 1,571,387 | 1,641,634 |
| Investments And Advances | 2,225,300 | 1,220,122 | 2,310,712 | 1,748,285 | 991,299 |
| Intangibles | 5,788,700 | 5,707,569 | 2,832,843 | 2,754,505 | 2,919,140 |
| Other Non-Current Assets | 0 | -1 | 0 | 0 | 0 |
| TOTAL | $9,779,700 | $8,678,400 | $6,885,755 | $6,074,177 | $5,552,073 |
| Total Assets | $14,314,700 | $11,863,330 | $10,130,120 | $9,049,604 | $8,092,493 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 229,200 | 219,913 | 203,999 | 186,448 | 162,529 |
| Accrued Expenses | 1,817,700 | 1,355,187 | 979,945 | 677,210 | 665,923 |
| TOTAL | $2,218,100 | $1,758,279 | $1,657,389 | $912,889 | $1,050,122 |
| Non-Current Liabilities | |||||
| Long Term Debt | 580,300 | 592,433 | 687,396 | 1,060,808 | 1,066,379 |
| Other Non-Current Liabilities | 643,300 | 659,231 | 604,266 | 368,018 | 432,299 |
| TOTAL | $1,282,600 | $1,484,218 | $1,508,934 | $1,709,728 | $1,592,928 |
| Total Liabilities | $3,500,700 | $3,242,497 | $3,166,323 | $2,622,617 | $2,643,050 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 234,615 | 236,000 | 236,312 | 238,725 | 240,912 |
| Common Shares | 100 | 128 | 127 | 128 | 124 |
| Retained earnings | 9,283,900 | 6,349,135 | 4,486,794 | 3,106,761 | 1,872,481 |
| Other shareholders' equity | -54,200 | -27,076 | -52,651 | -24,950 | 31,735 |
| TOTAL | $10,814,000 | $8,620,838 | $6,963,795 | $6,426,987 | $5,449,443 |
| Total Liabilities And Equity | $14,314,700 | $11,863,335 | $10,130,118 | $9,049,604 | $8,092,493 |